[go: up one dir, main page]

WO2002011694A3 - Compositions et formes posologiques en vue d'une application dans la cavite orale dans le cadre du traitement de mycoses - Google Patents

Compositions et formes posologiques en vue d'une application dans la cavite orale dans le cadre du traitement de mycoses Download PDF

Info

Publication number
WO2002011694A3
WO2002011694A3 PCT/EP2001/008978 EP0108978W WO0211694A3 WO 2002011694 A3 WO2002011694 A3 WO 2002011694A3 EP 0108978 W EP0108978 W EP 0108978W WO 0211694 A3 WO0211694 A3 WO 0211694A3
Authority
WO
WIPO (PCT)
Prior art keywords
application
oral cavity
mycosis
compositions
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2001/008978
Other languages
English (en)
Other versions
WO2002011694A2 (fr
Inventor
Joerg Rosenberg
Gunther Berndl
Joerg Neumann
Joerg Breitenbach
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott GmbH and Co KG
Original Assignee
Knoll GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll GmbH filed Critical Knoll GmbH
Priority to EP01976055A priority Critical patent/EP1305010B1/fr
Priority to US10/343,019 priority patent/US20040029892A1/en
Priority to AU2001295448A priority patent/AU2001295448A1/en
Priority to DE60102590T priority patent/DE60102590T2/de
Priority to BR0112847-7A priority patent/BR0112847A/pt
Priority to CA2417709A priority patent/CA2417709C/fr
Priority to JP2002517032A priority patent/JP2004505905A/ja
Priority to AT01976055T priority patent/ATE262893T1/de
Publication of WO2002011694A2 publication Critical patent/WO2002011694A2/fr
Publication of WO2002011694A3 publication Critical patent/WO2002011694A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
PCT/EP2001/008978 2000-08-03 2001-08-02 Compositions et formes posologiques en vue d'une application dans la cavite orale dans le cadre du traitement de mycoses Ceased WO2002011694A2 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
EP01976055A EP1305010B1 (fr) 2000-08-03 2001-08-02 Formes posologiques pour le traitement de mycoses orales
US10/343,019 US20040029892A1 (en) 2000-08-03 2001-08-02 Compositions and dosage forms for application in the oral cavity in the treatment of mykoses
AU2001295448A AU2001295448A1 (en) 2000-08-03 2001-08-02 Compositions and dosage forms for application in the oral cavity in the treatment of mykoses
DE60102590T DE60102590T2 (de) 2000-08-03 2001-08-02 Darreichungsformen zur behandlung von oralen mykosen
BR0112847-7A BR0112847A (pt) 2000-08-03 2001-08-02 Uso de uma forma de dosagem sólida
CA2417709A CA2417709C (fr) 2000-08-03 2001-08-02 Compositions et formes posologiques en vue d'une application dans la cavite orale dans le cadre du traitement de mycoses
JP2002517032A JP2004505905A (ja) 2000-08-03 2001-08-02 真菌症の治療における口腔内に適用する組成物および剤形
AT01976055T ATE262893T1 (de) 2000-08-03 2001-08-02 Darreichungsformen zur behandlung von oralen mykosen

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10038571A DE10038571A1 (de) 2000-08-03 2000-08-03 Zusammensetzungen und Dosierungsformen zur Anwendung in der Mundhöhle bei der Bhandlung von Mykosen
DE10038571.0 2000-08-03

Publications (2)

Publication Number Publication Date
WO2002011694A2 WO2002011694A2 (fr) 2002-02-14
WO2002011694A3 true WO2002011694A3 (fr) 2002-04-25

Family

ID=7651652

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/008978 Ceased WO2002011694A2 (fr) 2000-08-03 2001-08-02 Compositions et formes posologiques en vue d'une application dans la cavite orale dans le cadre du traitement de mycoses

Country Status (13)

Country Link
US (1) US20040029892A1 (fr)
EP (1) EP1305010B1 (fr)
JP (1) JP2004505905A (fr)
CN (1) CN1274297C (fr)
AT (1) ATE262893T1 (fr)
AU (1) AU2001295448A1 (fr)
BR (1) BR0112847A (fr)
CA (1) CA2417709C (fr)
DE (2) DE10038571A1 (fr)
ES (1) ES2218456T3 (fr)
RU (1) RU2003105812A (fr)
WO (1) WO2002011694A2 (fr)
ZA (1) ZA200301672B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7364752B1 (en) 1999-11-12 2008-04-29 Abbott Laboratories Solid dispersion pharamaceutical formulations
JP5767429B2 (ja) * 1999-11-12 2015-08-19 アッヴィ・インコーポレイテッド 固体分散剤中の結晶化阻害剤
DE10026698A1 (de) * 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
CN1309425C (zh) * 2001-11-05 2007-04-11 奥拉黑尔斯公司 用贴片治疗口腔溃疡以加速痊愈和缓解疼痛的方法
EP1521571A1 (fr) 2002-07-04 2005-04-13 Janssen Pharmaceutica N.V. Dispersions solides comprenant deux matrices polymeriques distinctes
DE10332160A1 (de) * 2003-07-15 2005-02-03 Röhm GmbH & Co. KG Multipartikuläre Arzneiform, enthaltend mucoadhaesiv formulierte Peptid- oder Protein-Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) * 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
CA2548376A1 (fr) 2003-12-31 2005-07-21 Pfizer Products Inc. Compositions solides a base de medicaments peu solubles et de poloxameres
CN1294912C (zh) * 2004-03-01 2007-01-17 上海医药工业研究院 伊曲康唑盐酸盐组合物及其冻干粉针
JP2006096728A (ja) * 2004-09-30 2006-04-13 Kobayashi Pharmaceut Co Ltd 口腔内定着型固形製剤
US20070048369A1 (en) * 2005-08-26 2007-03-01 National Starch And Chemical Investment Holding Corporation Mucosal delivery tablet
WO2007139661A1 (fr) * 2006-05-23 2007-12-06 Haley Jeffrey T Trochisques à base de xilitol et leurs procédés d'utilisation
CN101108172B (zh) * 2006-07-17 2010-10-06 天津药物研究院 一种口腔粘贴片及其制备方法
GB0703998D0 (en) 2007-03-01 2007-04-11 Glaxo Group Ltd Novel salt
BR112013008737A2 (pt) * 2010-10-14 2015-09-01 Abbott Gmbh & Co Kg Formulação de dispersão sólida de curcuminóide
FR2972327B1 (fr) * 2011-03-11 2017-08-11 Laboratoires Le Stum Composition nutraceutique mucoadhesive comprenant une association d'antioxydants

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0240906A2 (fr) * 1986-04-11 1987-10-14 BASF Aktiengesellschaft Procédé pour pastiller en continu
EP0250187A2 (fr) * 1986-06-16 1987-12-23 JOHNSON & JOHNSON CONSUMER PRODUCTS, INC. Film bioadhésif extrudé pour la libération intra-orale d'un médicament et procédé
WO1993018757A1 (fr) * 1992-03-17 1993-09-30 Pfizer Inc. Procede de fabrication concernant des comprimes poreux
US5431915A (en) * 1993-12-20 1995-07-11 Harvey; Bryce M. Frozen oral medication delivery system and method
US5578315A (en) * 1993-12-01 1996-11-26 Rutgers, The State University Of New Jersey Mucosal adhesive device for long-acting delivery of pharmaceutical combinations in oral cavity
DE19539359A1 (de) * 1995-10-23 1997-04-24 Knoll Ag Formbandkalander
WO1997044014A1 (fr) * 1996-05-20 1997-11-27 Janssen Pharmaceutica N.V. Compositions antifongiques avec biodisponibilite amelioree
EP0864326A2 (fr) * 1997-03-12 1998-09-16 Knoll Ag Préparation multiphasique comprenant un agent actif

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0920680A (ja) * 1995-01-24 1997-01-21 Hideyo Yamaguchi 抗真菌剤

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0240906A2 (fr) * 1986-04-11 1987-10-14 BASF Aktiengesellschaft Procédé pour pastiller en continu
EP0250187A2 (fr) * 1986-06-16 1987-12-23 JOHNSON & JOHNSON CONSUMER PRODUCTS, INC. Film bioadhésif extrudé pour la libération intra-orale d'un médicament et procédé
WO1993018757A1 (fr) * 1992-03-17 1993-09-30 Pfizer Inc. Procede de fabrication concernant des comprimes poreux
US5578315A (en) * 1993-12-01 1996-11-26 Rutgers, The State University Of New Jersey Mucosal adhesive device for long-acting delivery of pharmaceutical combinations in oral cavity
US5431915A (en) * 1993-12-20 1995-07-11 Harvey; Bryce M. Frozen oral medication delivery system and method
DE19539359A1 (de) * 1995-10-23 1997-04-24 Knoll Ag Formbandkalander
WO1997044014A1 (fr) * 1996-05-20 1997-11-27 Janssen Pharmaceutica N.V. Compositions antifongiques avec biodisponibilite amelioree
EP0864326A2 (fr) * 1997-03-12 1998-09-16 Knoll Ag Préparation multiphasique comprenant un agent actif

Also Published As

Publication number Publication date
BR0112847A (pt) 2003-06-24
ATE262893T1 (de) 2004-04-15
US20040029892A1 (en) 2004-02-12
ZA200301672B (en) 2004-03-01
JP2004505905A (ja) 2004-02-26
DE60102590D1 (de) 2004-05-06
DE10038571A1 (de) 2002-02-14
EP1305010B1 (fr) 2004-03-31
CN1444473A (zh) 2003-09-24
AU2001295448A1 (en) 2002-02-18
ES2218456T3 (es) 2004-11-16
CN1274297C (zh) 2006-09-13
RU2003105812A (ru) 2004-09-27
CA2417709A1 (fr) 2002-02-14
DE60102590T2 (de) 2005-04-21
CA2417709C (fr) 2010-05-11
WO2002011694A2 (fr) 2002-02-14
EP1305010A2 (fr) 2003-05-02

Similar Documents

Publication Publication Date Title
WO2002011694A3 (fr) Compositions et formes posologiques en vue d'une application dans la cavite orale dans le cadre du traitement de mycoses
CU20000176A7 (es) Composiciones de celecoxib
BR0312870A (pt) Comprimido de liberação sustentada compreendendo reboxetina
BR0009437A (pt) Amido pré-gelatinizado em uma formulação de liberação controlada
BR0014383A (pt) Composições de liberação controlada compreendendo nimesulida
DK1348429T3 (da) Smelteekstruderede opioidformuleringer, der kan administreres oralt
BR9808888A (pt) Formas de dosagem e método de melhorar disfunção erétil masculina
MA29744B1 (fr) Formulations posologiques solides de medicaments presentant une adsorption buccale amelioree
TW200505498A (en) Sugar-free oral transmucosal solid dosage forms and uses thereof
SE0102036D0 (sv) Pharmaceutical formulation for the efficient administration of apomorphine, 6aR- (-) -N- Propyl- norapomorphine and their derivatives and pro-drugs thereof
ATE541562T1 (de) Ibuprofen-suspension
ECSP003807A (es) Composiciones valdecoxib
DE602004009552D1 (de) Orales abgabesystem mit einem antibakteriellen und einem entzündungshemmenden mittel
BRPI0412364A (pt) composição farmacêutica sólida, compreendendo amisulpride
SE9902935D0 (sv) Pharmaceutical compositions
HUP0203148A2 (hu) Mirtazapint tartalmazó orálisan dezintegrálódó készítmény
SE0001916D0 (sv) Novel formulation
SE9902937D0 (sv) Pharmaceutical compositions
HRP20020258B1 (hr) Farmaceutska kombinacija etinilestradiola i drospirenona za upotrebu kao kontracepcijskog sredstva
GEP20043377B (en) Pharmaceutical Complex
SE9902936D0 (sv) Pharmaceutical compositions
PL1499278T3 (pl) Farmaceutyczna postać użytkowa o natychmiastowym uwalnianiu zawierająca polimorficzny tibolon
IT1320772B1 (it) Composizione farmaceutica a base di agenti attivi contro la candidaper il trattamento di disturbi della mucosa orale e intestinale
PA8508401A1 (es) Composiciones de valdecoxib
BG104303A (bg) носител за лекарствени средства за интраназално приложение и лекарствени форми с този носител

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 018135765

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 2001976055

Country of ref document: EP

Ref document number: 2417709

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002517032

Country of ref document: JP

Ref document number: 2001295448

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2003/01672

Country of ref document: ZA

Ref document number: 200301672

Country of ref document: ZA

ENP Entry into the national phase

Ref document number: 2003105812

Country of ref document: RU

Kind code of ref document: A

Ref country code: RU

Ref document number: RU A

WWP Wipo information: published in national office

Ref document number: 2001976055

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10343019

Country of ref document: US

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 2001976055

Country of ref document: EP